Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review

BACKGROUND: The results of randomized controlled (RCT) and retrospective studies have expanded the armamentarium of drugs for systemic sclerosis (SSc) – interstitial lung disease (ILD) treatment. The correct positioning of these drugs is not yet clarified. OBJECTIVES: Systemic literature review (SLR...

Descripción completa

Detalles Bibliográficos
Autores principales: Campochiaro, Corrado, Lazzaroni, Maria Grazia, Bruni, Cosimo, Zanatta, Elisabetta, De Luca, Giacomo, Matucci-Cerinic, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Interstitial Lung Disease in Autoimmune Rheumatic Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425887/
https://www.ncbi.nlm.nih.gov/pubmed/36051631
http://dx.doi.org/10.1177/1759720X221116408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425887/
https://www.ncbi.nlm.nih.gov/pubmed/36051631
http://dx.doi.org/10.1177/1759720X221116408

Ejemplares similares